{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T19:27:56Z","timestamp":1775762876750,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0009662","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000}}],"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["ISCIII-AES projects: PI18CIII\/00028 and DTS16III10"],"award-info":[{"award-number":["ISCIII-AES projects: PI18CIII\/00028 and DTS16III10"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["RD16CIII\/0003\/0002 Red de Enfermedades Tropicales, Subprograma RETICS del Plan Estatal de I+D+I 2013\u20132016, co-funded by FEDER \u201cUna manera de hacer Europa\u201d funds"],"award-info":[{"award-number":["RD16CIII\/0003\/0002 Red de Enfermedades Tropicales, Subprograma RETICS del Plan Estatal de I+D+I 2013\u20132016, co-funded by FEDER \u201cUna manera de hacer Europa\u201d funds"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Visceral leishmaniasis (VL) in patients receiving immunosuppressant drugs for autoimmune disease has been on the rise. It is important\u2014but difficult\u2014to know when cure has been achieved in these patients since the withdrawal of immunosuppressants during antileishmania treatment is commonly required, and there is a risk of relapse when immunosuppression is restored. The prevalence of asymptomatic infection among those immunosuppressed for autoimmune disease is also uncertain. The present work describes how cytokine release assays can be used to confirm the cure of VL, and to determine the prevalence of asymptomatic infection, in such patients. After collection of blood from volunteers (n = 108), SLA-stimulation of peripheral blood mononuclear cell cultures and of whole blood was found to induce the production of different combinations of cytokines that served to confirm recovery from VL, and asymptomatic <jats:italic>Leishmania<\/jats:italic> infection. Indeed, cure was confirmed in 14 patients, all of whom showed a specific Th1 immune response against <jats:italic>Leishmania<\/jats:italic>, and the prevalence of asymptomatic infection was determined as 21.27%. Cytokine profiles could be used to manage VL in patients with autoimmune disease, and to identify and better protect those with asymptomatic infection who are at risk of developing this disease.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009662","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T17:42:37Z","timestamp":1627926157000},"page":"e0009662","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":15,"title":["Leishmaniasis: A new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2652-9880","authenticated-orcid":true,"given":"Laura","family":"Botana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Victoria","family":"Ibarra-Meneses","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Belen","family":"Matia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4457-5124","authenticated-orcid":true,"given":"Juan Victor","family":"San Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0087-4659","authenticated-orcid":true,"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7869-7915","authenticated-orcid":true,"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,8,2]]},"reference":[{"key":"pntd.0009662.ref001","unstructured":"WHO. Control of the Leishmaniasis. Report of meeting of the WHO expert committee2010 2010."},{"issue":"12","key":"pntd.0009662.ref002","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.pt.2013.10.007","article-title":"What is responsible for a large and unusual outbreak of leishmaniasis in Madrid?","volume":"29","author":"E Carrillo","year":"2013","journal-title":"Trends Parasitol"},{"issue":"4","key":"pntd.0009662.ref003","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1469-0691.12556","article-title":"Leishmaniasis in immunosuppressed individuals","volume":"20","author":"J van Griensven","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"9764","key":"pntd.0009662.ref004","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(10)62237-4","article-title":"Combination therapy for visceral leishmaniasis","volume":"377","author":"J van Griensven","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"pntd.0009662.ref005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10096-011-1276-0","article-title":"Leishmaniasis: new insights from an old and neglected disease","volume":"31","author":"S Antinori","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"2","key":"pntd.0009662.ref006","first-page":"186","article-title":"Leishmania in SLE mimicking an exacerbation","volume":"24","author":"A Ossandon","year":"2006","journal-title":"Clin Exp Rheumatol"},{"issue":"Suppl 2","key":"pntd.0009662.ref007","doi-asserted-by":"crossref","first-page":"i60","DOI":"10.1136\/annrheumdis-2011-200596","article-title":"Leishmaniasis in rheumatology, haematology and oncology: epidemiological, immunological and clinical aspects and caveats","volume":"71","author":"C Bogdan","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"pntd.0009662.ref008","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1365-3083.2005.01686.x","article-title":"Immune response in human visceral leishmaniasis: analysis of the correlation between innate immunity cytokine profile and disease outcome","volume":"62","author":"V Peruhype-Magalhaes","year":"2005","journal-title":"Scand J Immunol"},{"issue":"6","key":"pntd.0009662.ref009","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.trstmh.2008.02.007","article-title":"Combined diagnostic methods identify a remarkable proportion of asymptomatic Leishmania (Leishmania) chagasi carriers who present modulated cytokine profiles","volume":"102","author":"L de Gouvea Viana","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"pntd.0009662.ref010","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.actatropica.2016.09.026","article-title":"Lymphoproliferative response after stimulation with soluble leishmania antigen (SLA) as a predictor of visceral leishmaniasis (VL) relapse in HIV+ patients","volume":"164","author":"A Castro","year":"2016","journal-title":"Acta Trop"},{"issue":"6","key":"pntd.0009662.ref011","doi-asserted-by":"crossref","first-page":"e0007461","DOI":"10.1371\/journal.pntd.0007461","article-title":"Asymptomatic immune responders to Leishmania among HIV positive patients","volume":"13","author":"L Botana","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"pntd.0009662.ref012","doi-asserted-by":"crossref","first-page":"e0004179","DOI":"10.1371\/journal.pntd.0004179","article-title":"Cytokine Release Assays as Tests for Exposure to Leishmania, and for Confirming Cure from Leishmaniasis, in Solid Organ Transplant Recipients","volume":"9","author":"E Carrillo","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"pntd.0009662.ref013","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.4049\/jimmunol.174.6.3598","article-title":"Mechanisms of the natural reactivity of lymphocytes from noninfected individuals to membrane-associated Leishmania infantum antigens","volume":"174","author":"A Sassi","year":"2005","journal-title":"J Immunol"},{"key":"pntd.0009662.ref014","first-page":"114","volume-title":"Parasite Antigens, Parasite Genes: A Laboratory Manual for Molecular Parasitology","author":"RM Maizels","year":"1991"},{"issue":"Suppl 1","key":"pntd.0009662.ref015","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0035-9203(02)90074-X","article-title":"A nested polymerase chain reaction (Ln-PCR) for diagnosing and monitoring Leishmania infantum infection in patients co-infected with human immunodeficiency virus","volume":"96","author":"I Cruz","year":"2002","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"pntd.0009662.ref016","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1186\/s13071-019-3628-z","article-title":"Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?","volume":"12","author":"L Horrillo","year":"2019","journal-title":"Parasit Vectors"},{"issue":"6","key":"pntd.0009662.ref017","doi-asserted-by":"crossref","first-page":"764","DOI":"10.4269\/ajtmh.1992.47.764","article-title":"Western blot analysis of antibodies to Leishmania infantum antigens: potential of the 14-kD and 16-kD antigens for diagnosis and epidemiologic purposes","volume":"47","author":"C Mary","year":"1992","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"pntd.0009662.ref018","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S1473-3099(08)70043-4","article-title":"Leishmaniasis among organ transplant recipients","volume":"8","author":"S Antinori","year":"2008","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"pntd.0009662.ref019","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/RHU.0b013e3181c8aa33","article-title":"An atypical presentation of visceral leishmaniasis infection in a patient with rheumatoid arthritis treated with infliximab","volume":"16","author":"K Kritikos","year":"2010","journal-title":"J Clin Rheumatol"},{"issue":"3","key":"pntd.0009662.ref020","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00281-020-00796-y","article-title":"Implications of asymptomatic infection for the natural history of selected parasitic tropical diseases","volume":"42","author":"J Alvar","year":"2020","journal-title":"Semin Immunopathol"},{"issue":"1","key":"pntd.0009662.ref021","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5588\/pha.13.0084","article-title":"Active and passive case detection strategies for the control of leishmaniasis in Bangladesh","volume":"4","author":"AK Das","year":"2014","journal-title":"Public Health Action"},{"issue":"10","key":"pntd.0009662.ref022","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/cid\/ciu102","article-title":"Asymptomatic Leishmania infection: a new challenge for Leishmania control","volume":"58","author":"OP Singh","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"2\u20133","key":"pntd.0009662.ref023","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.actatropica.2011.05.012","article-title":"Importance of worldwide asymptomatic carriers of Leishmania infantum (L. chagasi) in human","volume":"119","author":"G Michel","year":"2011","journal-title":"Acta Trop"},{"issue":"2","key":"pntd.0009662.ref024","doi-asserted-by":"crossref","first-page":"e2053","DOI":"10.1371\/journal.pntd.0002053","article-title":"Latent infection with Leishmania donovani in highly endemic villages in Bihar, India","volume":"7","author":"E Hasker","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"pntd.0009662.ref025","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1179\/000349809X12554106963555","article-title":"Visceral leishmaniasis in Aba-Roba, south-western Ethiopia: prevalence and incidence of active and subclinical infections","volume":"103","author":"A Hailu","year":"2009","journal-title":"Ann Trop Med Parasitol"},{"key":"pntd.0009662.ref026","article-title":"Prevalence of asymptomatic Leishmania infection and associated risk factors after an outbreak in the south-west of the Madrid area (Spain)","author":"AEC Ibarra-Meneses","year":"2019","journal-title":"Eurosurvillance"},{"key":"pntd.0009662.ref027","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3389\/fcimb.2017.00200","article-title":"IFN-gamma, IL-2, IP-10, and MIG as Biomarkers of Exposure to Leishmania spp., and of Cure in Human Visceral Leishmaniasis","volume":"7","author":"AV Ibarra-Meneses","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"pntd.0009662.ref028","doi-asserted-by":"crossref","first-page":"104444","DOI":"10.1016\/j.micpath.2020.104444","article-title":"Prediction of molecular mimicry between antigens from Leishmania sp. and human: Implications for autoimmune response in systemic lupus erythematosus","volume":"148","author":"M Munera","year":"2020","journal-title":"Microb Pathog"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0009662","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T00:00:00Z","timestamp":1628726400000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009662","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,12]],"date-time":"2021-08-12T19:19:57Z","timestamp":1628795997000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009662"}},"subtitle":[],"editor":[{"given":"Claudia Ida","family":"Brodskyn","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,8,2]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,8,2]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009662","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0009662","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,2]]}}}